| Virksomhedsstatus | | NORMAL. |
| Sidst opdateret den 18.02.2015 og
angivet som gældende fra 01.03.2014 (3872
dage). |
| Historik | Start | Stop |
|---|
| NORMAL | 01.03.2014 | |
| UDEN RETSVIRKNING | 26.02.2014 | 28.02.2014 |
| Branche | | Forskning og eksperimentel udvikling indenfor bioteknologi (721100). |
| Sidst opdateret den 19.02.2015 og
angivet som gældende fra 19.02.2015 (3517
dage). |
| Historik | Start | Stop |
|---|
| Forskning og eksperimentel udvikling indenfor bioteknologi (721100) | 19.02.2015 | |
| Engroshandel med computere, ydre enheder og software (465100) | 01.08.2014 | 18.02.2015 |
| Uoplyst (999999) | 26.02.2014 | 31.07.2014 |
| Revisionfravalgt | | false. |
| Sidst opdateret den 26.11.2020 og
angivet som gældende fra 02.11.2020 (1434
dage). |
| Historik | Start | Stop |
|---|
| false | 02.11.2020 | |
| true | 26.02.2014 | 01.11.2020 |
| Kontaktoplysninger | | mail@celvivo.com. |
| Sidst opdateret den 27.04.2020 og
angivet som gældende fra 27.04.2020 (1623
dage). |
| Historik | Start | Stop |
|---|
| mail@celvivo.com | 27.04.2020 | |
| sjfey@yahoo.co.uk | 19.02.2015 | 26.04.2020 |
| Telefonnummer | | 70228228. |
| Sidst opdateret den 13.05.2024 og
angivet som gældende fra 13.05.2024 (146
dage). |
| Historik | Start | Stop |
|---|
| 70228228 | 13.05.2024 | |
| 51177227 | 19.02.2015 | 27.04.2020 |
| Navne | | CELVIVO ApS. |
| Sidst opdateret den 24.09.2019 og
angivet som gældende fra 02.09.2019 (1861
dage). |
| Historik | Start | Stop |
|---|
| CELVIVO ApS | 02.09.2019 | |
| CELVIVO IVS | 26.02.2014 | 01.09.2019 |
| Tegningsregel | | Virksomheden tegnes af en direktør. |
| Sidst opdateret den 01.07.2019 og
angivet som gældende fra 01.07.2019 (1924
dage). |
| Fortolkning
(1 tegningsmulighed)
| | 1 direktør |
| Historik | Start | Stop |
|---|
| Virksomheden tegnes af en direktør | 01.07.2019 | |
| Selskabet forpligtes ved aftaler, som indgås på selskabets vegne af den samlede bestyrelse eller af en direktør i forening med et bestyrelsesmedlem | 26.02.2014 | 30.06.2019 |
Type af revisorbistand:Revisionspåtegning
Navn på revisionsvirksomhed:Christensen Kjærulff, Statsautoriseret Revisionsaktieselskab
Revisionsvirksomhedens CVR-nr.:15915641
Beskrivelse af revisor:statsautoriseret revisor
Virksomhedens regnskabsklasse:Regnskabsklasse B
Grundlag for konklusion (revision):Basis for Opinion
We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the “Auditor’s Responsibilities for the Audit of the Financial Statements” section of our report. We are independent of the Company in accordance with the International Ethics Standards Board for Accountants’ International Code of Ethics for Professional Accountants (IESBA Code) and the additional ethical requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements and the IESBA Code. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.
Konklusion (revision):We have audited the financial statements of Celvivo ApS for the financial year 1 October 2022 - 30 September 2023, which comprise income statement, balance sheet, statement of changes in equity, notes and a summary of significant accounting policies, for the Company. The financial statements are prepared under the Danish Financial Statements Act.
In our opinion, the financial statements give a true and fair view of the financial position of the Company at 30 September 2023, and of the results of the Company's operations for the financial year 1 October 2022 - 30 September 2023 in accordance with the Danish Financial Statements Act.
Udtalelse om ledelsesberetningen (revision):Statement on Management’s Review
Management is responsible for Management’s Review.
Our opinion on the financial statements døs not cover Management’s Review, and we do not express any form of assurance conclusion thereon.
In connection with our audit of the financial statements, our responsibility is to read Management’s Review and, in doing so, consider whether Management’s Review is materially inconsistent with the financial statements or our knowledge obtained during the audit, or otherwise appears to be materially misstated.
Moreover, it is our responsibility to consider whether Management’s Review provides the information required under the Danish Financial Statements Act.
Based on the work we have performed, we conclude that Management’s Review is in accordance with the financial statements and has been prepared in accordance with the requirements of the Danish Financial Statement Act. We did not identify any material misstatement of Management’s Review.
Ingen nuværende registrering.
Ingen historik.
Ingen nuværende registrering.
Ingen historik.
Ingen nuværende registrering.
Ingen historik.
LoginOpret gratis brugere-conomic integration